SPRINGFIELD, Ill. - The American Cancer Society Cancer Action Network (ACS CAN) is encouraged to see the Illinois legislature pass and Gov. J.B. Pritzker sign legislation to allow Illinois Medicaid recipients access to possible life-saving clinical trials.
Today the U.S. House of Representatives is expected to vote on a legislative package containing provisions aimed at improving access to affordable health care, including for those with serious pre-existing conditions like cancer.
The American Cancer Society Cancer Action Network (ACS CAN) submitted testimony today to the House Energy and Commerce Committee on the topic of racial and ethnic disparities in the health care system that often result in an unequal cancer burden. The hearing is focused on disparities in the overall health care system, as well as those around COVID-19.
Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule. The rule, finalized Friday, attempts to undermine Section 1557 of the Affordable Care Act by removing explicit protections against discrimination of patients by providers and institutions.
A new survey shows that cancer patients are being impacted by COVID-19.
Untold insecurities weigh heavily on many Oklahomans, and on June 30, voters can ease some of that worry by voting ‘yes’ on State Question 802.
Today the U.S. House of Representatives will vote on the Heroes Act, a package of legislative proposals aimed at addressing numerous pandemic-related health, research and economic relief needs. Included in the bill are several provisions that would make it easier for Americans to maintain or gain health insurance coverage.
Twenty patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae (“friend-of-the-court”) brief today with the U.S. Supreme Court in the case California v. Texas (previously Texas v. United States), citing the devastating impact patients would face should the court rule to invalidate the Affordable Care Act (ACA).
he Centers for Medicare and Medicaid Services (CMS) recently issued a proposed rule detailing how the government would cover costs for Chimeric antigen receptor (CAR) T-cell cancer therapy for Medicare enrollees.
Legislation introduced in the U.S. House of Representatives today aims to improve access to quality health care for communities of color and decrease health disparities, such as those resulting in a disproportionate number of COVID-19 cases and deaths in these communities.